For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the emergence of this treatment and Attruby represents a genuine breakthrough . These innovative therapies protect the transthyretin protein, slowing its harmful build-up and reducing the impact of the condition . People are now experiencing improv